Theravance Biopharma, Inc. (TBPH)
Since Aug 13, 2014, Theravance Biopharma, Inc. (TBPH) has reported earnings 48 times. On average the shares move ±5.20% post-earnings, with a positive reaction 47.9% of the time. Its largest post-earnings gain was +22.68% (Nov 10, 2025) and its largest decline was -19.84% (Aug 08, 2017). The next earnings report is predicted for 2026-11-11 (estimated).
Earnings reactions
How TBPH moved on each past earnings report.
Earnings Impact
Total Earnings
48
Avg Abs. Movement
±5.20%
Positive %
47.9%
Negative %
52.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 10, 2026 | ☀ PRE | -0.21% | open_in_new |
| May 07, 2026 | ☀ PRE | +0.44% | open_in_new |
| Mar 19, 2026 | ☀ PRE | +1.3% | open_in_new |
| Nov 10, 2025 | ☽ POST | +22.68% | open_in_new |
Earnings Count
48
Total earnings in dataset
Avg Abs. Movement
±5.20%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260825 | open_in_new SEC.gov |
| DEFA14A | 20260825 | open_in_new SEC.gov |
| 4 | 20260824 | open_in_new SEC.gov |
| 4 | 20260824 | open_in_new SEC.gov |
| 4 | 20260824 | open_in_new SEC.gov |
| 4 | 20260824 | open_in_new SEC.gov |
| 4 | 20260824 | open_in_new SEC.gov |
| DEFM14A | 20260821 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
Frequently asked about TBPH earnings
When does Theravance Biopharma, Inc. report earnings next? expand_more
Theravance Biopharma, Inc. (TBPH)'s next earnings date is estimated for 2026-11-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does TBPH stock move after earnings? expand_more
Over 48 reports, TBPH has moved an average of ±5.20% the session after earnings, closing higher 47.9% of the time.
What was TBPH's biggest post-earnings move? expand_more
TBPH's largest post-earnings gain on record was +22.68% on Nov 10, 2025, and its largest decline was -19.84% on Aug 08, 2017.
Where can I find Theravance Biopharma, Inc.'s SEC filings? expand_more
All of Theravance Biopharma, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right